Antitumor effect of miR-197 targeting in p53 wild-type lung cancer

Por Fiori, M E, Barbini, C, Haas, T L, Marroncelli, N, Patrizii, M, Biffoni, M, De Maria, R
Publicado em 2014

Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-X(L) inhibition in non-small cell lung cancer

Por Zeuner, A, Francescangeli, F, Contavalli, P, Zapparelli, G, Apuzzo, T, Eramo, A, Baiocchi, M, De Angelis, M L, Biffoni, M, Sette, G, Todaro, M, Stassi, G, De Maria, R
Publicado no Cell Death Differ (2014)

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome

Por Marziali, G., Signore, M., Buccarelli, M., Grande, S., Palma, A., Biffoni, M., Rosi, A., D’Alessandris, Q.G., Martini, M., Larocca, L. M., De Maria, R., Pallini, R., Ricci-Vitiani, L.
Publicado no Sci Rep (2016)

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo

Por Signore, M, Pelacchi, F, di Martino, S, Runci, D, Biffoni, M, Giannetti, S, Morgante, L, De Majo, M, Petricoin, E F, Stancato, L, Larocca, L M, De Maria, R, Pallini, R, Ricci-Vitiani, L
Publicado em 2014

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy

Por Bartucci, M, Svensson, S, Romania, P, Dattilo, R, Patrizii, M, Signore, M, Navarra, S, Lotti, F, Biffoni, M, Pilozzi, E, Duranti, E, Martinelli, S, Rinaldo, C, Zeuner, A, Maugeri-Saccà, M, Eramo, A, De Maria, R
Publicado em 2012